Application of glycine in improving reproductive performance of gilts and improving birth quality of piglets

By adding glycine to the diet of gilts during gestation, the density of placental blood vessels and the ability to transport nutrients are improved, which solves the problem of unstable sow reproductive performance in existing technologies and achieves the effects of improving pregnancy rate, litter birth quality and early growth performance of piglets.

CN123100742APending Publication Date: 2026-11-17JILIN AGRICULTURAL UNIV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202611352215.9
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2026-09-02
Publication Date
2026-11-17

AI Technical Summary

Technical Problem

Existing amino acid supplementation strategies have an unstable effect on improving the reproductive performance of gilts, making it difficult to increase the total number of piglets born and the number of live piglets. Furthermore, they have limited effect on increasing the litter weight and individual weight of piglets, making it difficult to achieve sustained effects from gestation to lactation.

Method used

Adding 1.0% glycine to the gestation diet of gilts and continuing to feed them until farrowing can increase the vascular density of the placental matrix and placental folds, and improve the placental nutrient transport capacity by upregulating the expression of related genes.

Benefits of technology

It improved the pregnancy rate of gilts, enhanced litter birth quality and early growth performance of piglets, reduced the proportion of low birth weight piglets, and increased litter birth weight and 28-day weaning weight.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN123100742A_ABST
    Figure CN123100742A_ABST
Patent Text Reader

Abstract

This invention belongs to the field of sow reproductive regulation technology, specifically involving the application of glycine in improving the reproductive performance of gilts and enhancing the birth quality of piglets. This invention involves adding 1.0% glycine to the basal diet of gilts, starting before mating and continuing until farrowing. Significant differences in pregnancy rates were observed among the treatments, with the glycine group showing higher rates than the basal diet control group. Simultaneously, the glycine group exhibited a significantly lower proportion of low birth weight piglets, while significantly increased litter weight at birth, litter weight at 28 days of weaning, and average individual weight of piglets at 28 days of age. Furthermore, glycine supplementation was accompanied by changes in the maternal gut microbiota structure and fecal metabolic characteristics during late pregnancy, with a significant enrichment of purine metabolic pathways. Additionally, glycine supplementation increased placental vascular density and upregulated the expression of KDR, NOS3 genes, and genes related to amino acid and fatty acid transport, thereby improving placental vascular and nutrient transport-related traits and promoting fetal development and early piglet growth.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention belongs to the field of sow reproductive regulation technology, specifically involving the application of glycine in improving the reproductive performance of gilts and improving the birth quality of piglets. Background Technology

[0002] Replacement gilts are a crucial foundation for the renewal of breeding herds and the long-term productivity of farms. Their first-parity reproductive performance directly affects litter size, piglet birth quality, lactation survival rate, and subsequent sow utilization efficiency. Gestation is a critical stage for embryo survival, placental formation, rapid fetal growth, and maternal metabolic adaptation. During this stage, maternal nutrient supply not only affects fetal development but also placental structure, nutrient transport capacity, and the growth potential of piglets after birth.

[0003] Currently, nutritional regulation techniques for pregnant sows mainly focus on adjusting energy and crude protein levels, as well as the balanced supply of conventional essential amino acids such as lysine, methionine, threonine, and tryptophan. In recent years, functional amino acids such as arginine and glutamine have attracted attention for improving placental development, fetal growth, and reproductive performance in pregnant sows. However, the effects of existing amino acid supplementation strategies on the reproductive performance of gilts are unstable, often failing to achieve statistical significance in core indicators such as total litter size and live piglet count. The improvement in litter weight and individual piglet weight is limited, and the effect on reducing the proportion of low birth weight piglets is unclear. Furthermore, existing amino acid supplementation programs lack sustained evidence of improved growth performance in piglets at weaning, making it difficult to achieve sustained effects from gestation to lactation, thus limiting the practical application of amino acid nutritional regulation strategies in young sow herds. Summary of the Invention

[0004] To address the aforementioned problems, this invention provides the application of glycine in improving the reproductive performance of gilts and enhancing the birth quality of piglets.

[0005] The technical solution of the present invention is as follows: Application of glycine in improving the reproductive performance of local black pig replacement sows, improving litter birth quality and early growth performance of piglets.

[0006] Furthermore, the improvements include increasing the pregnancy rate of gilts and the litter weight of piglets at birth, reducing the proportion of low birth weight piglets, and increasing the litter weight at 28 days of weaning and the average individual weight at 28 days of age.

[0007] Furthermore, the glycine is used to increase the placental matrix vascular density and placental fold vascular density in gilts, and to upregulate the expression of placental KDR, NOS3, SNAT1, SNAT2, FATP4 and CD36 genes.

[0008] Furthermore, the glycine is used as a feed additive and mixed with the daily basal diet for feeding gilts.

[0009] Furthermore, the basal diet is a complete compound feed that does not contain crystalline glycine.

[0010] Furthermore, the daily addition of glycine is 1.0% of the daily basal diet of the gilts.

[0011] Compared with the prior art, the present invention has the following beneficial effects: This invention is the first to discover that adding 1.0% glycine to the diet of gilts before mating and during gestation, and continuing to feed it until farrowing, can improve the pregnancy rate of gilts, improve the birth quality of piglets in the first litter and the early growth performance of piglets, as manifested by increasing the litter weight at birth, the litter weight at 28 days of weaning and the average individual weight of piglets at 28 days of age, and reducing the proportion of low birth weight piglets.

[0012] Simultaneously, glycine supplementation was accompanied by changes in the composition of maternal gut microbiota and fecal metabolites during late pregnancy. Results from day 109 of gestation showed that glycine supplementation increased the relative abundance of Streptococcus in the maternal gut microbiota and decreased the relative abundance of CAG-873. Non-targeted metabolomics analysis identified 29 candidate differentially expressed metabolites associated with glycine supplementation, among which purine metabolic pathways were significantly enriched, with increased relative abundance of adenosine, guanosine, and cyclic guanosine monophosphate.

[0013] Histological and vascular density analyses of the placenta showed that glycine supplementation increased placental matrix vascular density and placental fold vascular density. Placental gene expression assays indicated that glycine supplementation upregulated the expression of vascular function-related genes such as KDR and NOS3, as well as amino acid and fatty acid transport-related genes such as SNAT1, SNAT2, FATP4, and CD36, suggesting that glycine has a role in improving placental vascular and nutrient transport-related traits. Attached Figure Description

[0014] Figure 1 Experimental design and sample collection timeline. CON = basal diet; ALA = basal diet + 1.19% L-alanine, as an isonitrogenous control; GLY = basal diet + 1.0% glycine; D−30 = 30 days before mating; D0 = day of mating; D30 = day 30 of gestation; D109 = day 109 of gestation.

[0015] Figure 2Effects of glycine supplementation during gestation on the composition, diversity, and candidate differentially expressed bacterial genera of the maternal gut microbiota in local black pig gilts. (A) The 20 most abundant phyla in fecal samples from D30 and D109. (B) The 20 most abundant genera in fecal samples from D30 and D109. (C, D) ASV Venn plots for D30 and D109. (E, F) α-diversity indices for D30 and D109. (G, H) PCoA score plots for D30 and D109 based on Bray-Curtis distance. (I, J) Genus-level clustering heatmaps of the 20 most abundant genera in D30 and D109. (K, L) LEfSe phylogenetic cladistics comparing CON with GLY and ALA with GLY at D109. (M, N) Relative abundance of CAG-873 and Streptococcus. Data in M ​​and N are expressed as mean ± SD. The LEfSe screening threshold was an LDA score > 2.0 and P < 0.05. *P < 0.05. CON = basal diet; ALA = basal diet + 1.19% L-alanine as an isonitrogenous control; GLY = basal diet + 1.0% glycine; D30 = day 30 of gestation; D109 = day 109 of gestation; ASV = amplicon sequence variant; PCoA = principal coordinate analysis; LEfSe = linear discriminant analysis effect size; LDA = linear discriminant analysis. At D30, n = 9 per treatment; at D109, n = 10 per treatment.

[0016] Figure 3: D109 fecal metabolomics characteristics and correlations between candidate genera and purine-related metabolites. (A, B) OPLS-DA score plots comparing CON with GLY and ALA with GLY under positive electrospray ionization mode. (C, D) Volcano plots of candidate differential metabolites comparing CON with GLY and ALA with GLY. (E) Number and direction of change of candidate differential metabolites in each pairwise comparison. (F) Number and direction of change of 29 candidate differential metabolites related to glycine. (G) Cluster heatmap of 29 candidate differential metabolites related to glycine. (H) KEGG pathway enrichment analysis of glycine-related candidate metabolites. (I) Normalized abundance of metabolites initially annotated as guanosine, adenosine, and cGMP. (J) Spearman correlation heatmap of Streptococcus and CAG-873 with 3 purine-related metabolites. In each comparison, an increase or decrease indicates the change in the second group relative to the first group. Data in I are expressed as mean ± SD. In the correlation heatmap, red and blue represent positive and negative correlations, respectively. *P<0.05; **P<0.01. CON = basal diet; ALA = basal diet + 1.19% L-alanine, as an isonitrogenous control; GLY = basal diet + 1.0% glycine; ESI+ = positive electrospray ionization mode; OPLS-DA = orthogonal partial least squares discriminant analysis; KEGG = Kyoto Encyclopedia of Genetics and Genomes; cGMP = cyclic guanosine monophosphate. Each treatment in AI has n = 10; J contains 30 paired observations of D109 microbiota-metabolome across the CON, ALA, and GLY groups.

[0017] Figure 4Effects of glycine supplementation during gestation on placental morphology, vascular density, and expression of genes related to angiogenesis and nutrient transport in local black pig gilts. (A) Gross morphology of representative placentas. (B) H&E-stained sections of representative placentas; the top and bottom rows show placental matrix at 40× and placental folds at 400×, respectively, with black arrows indicating blood vessels or capillaries. (C, D) PSVD and PFVD. (EG) Relative mRNA expression levels of VEGFA, NOS3, and KDR. (H, I) Relative mRNA expression levels of GLUT3 and GLUT4. (JM) Relative mRNA expression levels of SNAT1, SNAT2, FATP4, and CD36. Data in CM are expressed as mean ± SD; n = 5 per treatment. Scale bar: 5 cm (A), 200 μm (B, top row), and 20 μm (B, bottom row). *P<0.05; **P<0.01; ns, no significant difference. CON = basal diet; ALA = basal diet + 1.19% L-alanine, as an isonitrogenous control; GLY = basal diet + 1.0% glycine; H&E = hematoxylin-eosin staining; PSVD = placental matrix vascular density; PFVD = placental fold vascular density. Detailed Implementation

[0018] The present invention will now be described in detail with reference to the accompanying drawings and specific embodiments, but this should not be construed as limiting the invention. Unless otherwise specified, the technical means used in the following embodiments are conventional means well known to those skilled in the art, and the materials, reagents, etc. used in the following embodiments are commercially available unless otherwise specified.

[0019] The key terms and abbreviations used in the following embodiments are shown in Table 1: Table 1 Key Terms and Abbreviations the term English meaning replacement sows gilt Young sows that have not yet completed their first farrowing or are in the initial stage of reproductive use are the main target of this invention. Local black pigs local black pigs This refers to the black pig group with local germplasm resource characteristics involved in the experiments and applications of this invention. glycine glycine A non-essential amino acid is used as a feed additive in this invention to improve pregnancy outcomes, litter birth quality, placental vascularization, and nutrient transport-related traits in gilts. alanine alanine An amino acid, in this invention, can be used as an isonitrogenous control to eliminate the influence of simple nitrogen source supplementation on the experimental results. Nutritional regulation nutritional regulation This refers to the process of improving an animal's nutritional status, physiological function, and production performance by adjusting the composition of its diet or adding specific nutrients. gut microbiota gut microbiota This refers to the microbial community existing in the animal gut, which is used in this invention to evaluate the effects of glycine on the gut microecology of sows. Fecal metabolic characteristics fecal metabolic profile This refers to the composition, relative abundance, and related metabolic pathway characteristics of fecal metabolites obtained through non-targeted metabolomics detection. placenta placenta The term refers to the vital organ that connects the mother and fetus and participates in nutrient transport and gas exchange. It is an important tissue basis for evaluating the effect of glycine on reproductive performance in this invention. Placental vascular development placental vascular development The formation and changes in the number, density, and structure of blood vessels in placental tissue are closely related to fetal nutrition and development. Reproductive performance reproductive performance These are indicators related to the mating, pregnancy, and farrowing outcomes of sows, including pregnancy rate, total number of piglets born, number of live piglets born, stillbirth rate, litter weight of piglets at birth, and the proportion of low birth weight piglets. Pregnancy gestation period The period from mating and conception to farrowing is the main time period for nutritional intervention in this invention. CON control group The control group refers to the basal diet group that was not supplemented with glycine or alanine. ALA alanine group The alanine group refers to the isonitrogenous control group in which alanine is added to the basal diet. GLY glycine group The glycine group refers to the experimental group in which glycine was added to the basal diet. Gly glycine Glycine. Ala alanine Alanine. 16S rRNA 16S ribosomal RNA 16S ribosomal RNA is commonly used for gut microbiota composition analysis. KEGG Kyoto Encyclopedia of Genes and Genomes The Kyoto Encyclopedia of Genes and Genomes, used for metabolic pathway annotation and enrichment analysis. OPLS-DA orthogonal partialleast squaresdiscriminantanalysis Orthogonal partial least squares discriminant analysis is used to determine inter-group differences in metabolomics data. Candidate differential metabolites candidatedifferentialmetabolites Candidate metabolites whose relative abundance differs significantly among different treatment groups according to preset screening criteria. qPCR quantitative real-time polymerase chain reaction Real-time quantitative PCR is used to detect the expression levels of relevant genes. H&E staining Hematoxylin and eosin staining Hematoxylin-eosin staining is used to observe the morphology and structure of placental tissue. PFVD placental foldvascular density Placental fold vascular density refers to the number of blood vessels per unit area in the placental fold region, measured in vessels per mm². PSVD placental stromalvascular density Placental stromal vascular density refers to the percentage of the vascular area within the placental stromal region relative to the total stromal tissue area. VEGFA vascular endothelialgrowth factor A Vascular endothelial growth factor A is involved in angiogenesis and placental vascular development. KDR kinase insert domainreceptor VEGF receptor 2, also known as VEGFR2, is involved in angiogenesis signal transduction. NOS3 nitric oxide synthase 3 Nitric oxide synthase 3, also known as endothelial nitric oxide synthase, is involved in nitric oxide production, vasodilation, and regulation of vascular function. GLUT3 glucose transporter3 Glucose transporter 3 is involved in glucose uptake in the placenta or tissues. GLUT4 glucose transporter4 Glucose transporter 4 is involved in insulin-sensitive glucose transport. SNAT1 sodium-coupledneutral amino acidtransporter 1 Sodium-coupled neutral amino acid transporter 1 participates in amino acid transport. SNAT2 sodium-coupledneutral amino acidtransporter 2 Sodium-coupled neutral amino acid transporter 2 participates in the transport of neutral amino acids. CD36 cluster of differentiation 36 Fatty acid transport-related proteins are involved in the uptake of long-chain fatty acids. FATP4 fatty acid transport protein 4 Fatty acid transporter 4 is involved in fatty acid transport. D−30 30 days before mating The 30th day before mating is the time point at which glycine supplementation begins according to this invention. D0 day of mating On the day of mating. D30 gestation day 30 Day 30 of pregnancy. D109 gestation day 109 The 109th day of pregnancy is the time point for collecting stool samples in late pregnancy. ASV amplicon sequencevariant Amplicon sequence variants are used to characterize microbial sequence units obtained from 16S rRNA gene sequencing. PCoA principal coordinateanalysis Principal coordinate analysis was used to evaluate the differences in the overall structure of the gut microbiota among different treatment groups. LEfSe linear discriminantanalysis effect size Linear discriminant analysis and effect size analysis are used to screen for differentially enriched microbial taxa among different treatment groups. LDA linear discriminant analysis Linear discriminant analysis is used to evaluate the effect size of differentially expressed microbial communities. VIP variable importance in projection The importance of projected variables is used to evaluate the contribution of metabolites to the distinction between groups. cGMP cyclic guanosinemonophosphate Cyclic guanosine monophosphate (cGMP) is a metabolite involved in purine metabolism and regulation of vascular function. adenosine adenosine A purine nucleoside, which is one of the candidate metabolites with relatively increased abundance in the glycine group in this invention. Guanosine guanosine A purine nucleoside, which is one of the candidate metabolites with relatively increased abundance in the glycine group in this invention.

[0020] Example 1: A method for regulating glycine nutrition in pregnant gilts 1. Method 1.1 Experimental subjects and grouping Sixty healthy, similar-aged, and breeding-ready local black pig gilts were selected as experimental subjects. A completely randomized design was used to divide the gilts into three treatment groups of 20 each. All groups of gilts were raised under the same feeding management, immunization program, water conditions, and environmental conditions.

[0021] The experiment was set up with three treatment groups: (1) Control group CON: fed with basal diet; (2) Alanine-based control group (ALA): 1.19% L-alanine by weight was added to the basal diet; (3) Glycine group GLY: 1.0% of its mass of glycine was added to the basal diet.

[0022] In this study, the alanine group served as an isonitrogenous control, with the nitrogen provided by the added L-alanine being comparable to that provided by the added glycine in the glycine group. This was used to differentiate the effect of glycine supplementation from the effect of simply increasing dietary nitrogen levels. The composition of the basal diet is shown in Table 2. In this embodiment, each group initially consisted of 20 gilts, and the pregnancy rate was statistically analyzed using the initial 20 gilts in each group. After pregnancy was confirmed, 10 pregnant gilts were randomly selected from each group to record reproductive performance (excluding pregnancy rate) and early growth performance of piglets.

[0023] Table 2. Raw material composition and guaranteed nutritional level of basal diet for gilts and lactating sows (basic feeding status) project Feeding stage 1: Feed gilts with feed at a weight of 60-100 kg. Feeding Phase 2: Lactating sow feed from day 100 of gestation until next mating Raw material composition, g / kg corn 557.35 459.55 Soybean meal (43% crude protein) 148.05 186.00 wheat flour 80.00 80.00 Rice bran meal 60.00 50.00 rice bran 60.00 - bran 45.30 38.80 flour - 50.00 Corn DDGS (High Fat) - 20.00 Soybean skin - 20.00 glucose - 20.00 Soybean oil 10.00 15.00 fish meal - 15.00 Calcium hydrogen phosphate 12.40 10.25 fine stone powder 11.00 15.40 Sodium chloride 4.50 4.50 0.5% Vitamin-Mineral Premix 5.00 (5H53A)1 5.00 (5H53B)2 L-Lysine sulfate (70%) 3.70 - L-Lysine hydrochloride (98%) - 4.05 Choline chloride (60%) 1.00 1.50 L-threonine 0.85 1.80 L-methionine 0.55 1.25 L-valine - 1.45 L-Tryptophan 0.05 0.10 Mycotoxin adsorbent (brewer's yeast cell wall) 0.15 0.15 Preservative T60 0.10 0.20 total 1,000.00 1,000.00 Ensure nutritional level 3 Crude protein, g / kg ≥ 150 ≥ 170 Crude fiber, g / kg ≤ 80 ≤ 70 Coarse ash content, g / kg ≤ 100 ≤ 90 Moisture content, g / kg ≤ 140 ≤ 140 Calcium, g / kg 5~15 5~15 Total phosphorus, g / kg ≥ 5 ≥ 5 Sodium chloride, g / kg 3~8 3~12 Lysine, g / kg ≥ 10 ≥ 11 DDGS = Dried distiller's grains containing solubles.

[0024] 1 The addition rate of 5H53A premix to complete feed is 5.0 g / kg, providing the following nutrients per kilogram of premix: Fe, 20,000–90,000 mg; Cu, 1,600–5,000 mg; Zn, 8,000–20,000 mg; Mn, 8,000–30,000 mg; Se, 40–100 mg; Vitamin A, 1,600–2,400 kIU; Vitamin D3, 400–1,000 kIU; Vitamin E, ≥9,600 mg; Vitamin K3, ≥480 mg; Vitamin B1, ≥320 mg; Vitamin B2, ≥1,200 mg; Vitamin B6, ≥300 mg; Nicotinamide, ≥5,600 mg; Pantothenic acid, ≥3,200 mg.

[0025] 2 The addition rate of 5H53B premix to complete feed is 5.0 g / kg, providing the following nutrients per kilogram of premix: Fe, 20,000–90,000 mg; Cu, 1,600–5,000 mg; Zn, 8,000–20,000 mg; Mn, 8,000–30,000 mg; Se, 40–100 mg; Vitamin A, 1,000–1,400 kIU; Vitamin D3, 400–1,000 kIU; Vitamin E, ≥12,000 mg; Vitamin K3, ≥600 mg; Vitamin B1, ≥340 mg; Vitamin B2, ≥1,400 mg; Vitamin B6, ≥300 mg; Nicotinamide, ≥6,000 mg; Pantothenic acid, ≥4,000 mg.

[0026] 3 The ingredient composition is calculated based on the pig farm's production formula. Nutritional levels are compiled from the labels of commercial feeds and premixes, all expressed on a feeding status basis.

[0027] 1.2 Food Processing Plan The control group was fed a basal diet; the alanine group was fed a basal diet supplemented with 1.19% L-alanine; and the glycine group was fed a basal diet supplemented with 1.0% glycine.

[0028] When formulating the diets, except for the different additions of target amino acids, the basal formula, feeding regime, rearing environment, and management methods were kept consistent across all treatment groups. The basal diets were commercially available complete feeds commonly used in farms, with separate feeds for gilts and lactating sows used depending on the sow's rearing stage. No additional crystalline glycine was added to the basal diets. The glycine addition for the glycine group was calculated at 1.0% of the daily basal diet intake per sow; the L-alanine addition for the alanine group was calculated at 1.19% of the daily basal diet intake per sow.

[0029] Mix the required daily amount of glycine or L-alanine thoroughly with the basal diet given in the morning feed and feed once daily at 07:00. Sows in each group should be fed at 07:00 and 14:00 daily, and have free access to water.

[0030] The nutritional levels of energy, crude protein, essential amino acids, minerals, and vitamins in the basic diet meet the needs of gilts for normal growth, mating, and pregnancy.

[0031] 1.3 Feeding window The day of mating was designated as day 0 of gestation, or D0. Each treatment diet was started 30 days before mating and continued until parturition after estrus synchronization and mating. Supplementation with glycine or L-alanine was discontinued after parturition.

[0032] Fresh fecal samples were collected on days 30 and 109 of gestation for gut microbiota analysis; fecal samples were also collected on day 109 for non-targeted metabolomics analysis. Reproductive performance and piglet birth traits were recorded during farrowing, and placental samples were collected for histological morphology, vascular density, and related gene expression detection. The experimental design and sample collection timeline are detailed below. Figure 1 .

[0033] 1.4 Evaluation of reproductive performance and piglet growth performance Pregnancy was diagnosed using B-mode ultrasound approximately 28 days post-mating, and the result was confirmed by subsequent examinations. The pregnancy rate was calculated as the proportion of pregnant sows in each group to the initial 20 replacement gilts.

[0034] Record sow reproductive performance and piglet growth-related indicators after farrowing, including total number of piglets born, number of live piglets, number of stillbirths, stillbirth rate, number of low birth weight piglets, proportion of low birth weight piglets, birth litter weight, average birth weight of piglets, litter weight at 28 days of age, and average weaning weight of piglets at 28 days of age.

[0035] Low birth weight piglets are defined according to the standard set in this embodiment as live piglets with a birth weight of less than 0.9 kg.

[0036] The proportion of low birth weight piglets is calculated as the ratio of the number of low birth weight piglets to the total number of live piglets, and the stillbirth rate is calculated as the ratio of the number of stillbirths to the total number of piglets born.

[0037] All live piglets were individually weighed after birth to calculate the litter weight and average birth weight. At 28 days of age, the actual number of weaned piglets in each litter was recorded, and each weaned piglet was weighed to calculate the 28-day weaning litter weight and average individual weight of piglets at 28 days of age.

[0038] The representation of different types of data shall be performed in accordance with the statistical analysis method described in Section 1.10 of this embodiment.

[0039] 1.5 Intestinal flora detection Fresh fecal samples were collected on days 30 and 109 of pregnancy, and 16S rRNA gene sequencing was performed after cryopreservation.

[0040] The detection included ASV feature construction, Alpha diversity analysis, Beta diversity analysis, PCoA ordination analysis, phylum and genus level species composition analysis, and LEfSe differential bacterial analysis.

[0041] In this embodiment, according to the preset screening criteria, the glycine-related candidate genera obtained in the D109 stage were mainly Streptococcus and CAG-873, suggesting that glycine supplementation in late pregnancy may be related to changes in the maternal gut microbiota structure.

[0042] 1.6 Non-targeted metabolomics detection and screening of candidate differentially expressed metabolites related to glycine supplementation Fecal samples were collected on day 109 of pregnancy for non-targeted metabolomics testing.

[0043] OPLS-DA was used to visualize the metabolic profile distribution among different treatment groups. The selection criteria for candidate metabolic features were that both groups simultaneously met the criteria of VIP ≥ 1.0 and P < 0.05.

[0044] Pairwise comparisons were made between the CON group and the ALA group, the CON group and the GLY group, and the ALA group and the GLY group, and the detection results under positive and negative ion modes were combined at the metabolite level.

[0045] Candidate differential metabolites related to glycine supplementation were screened according to the following criteria: VIP≥1.0 and P<0.05 were met in comparisons between the CON group and the GLY group, and between the ALA group and the GLY group, and the corresponding metabolites showed the same direction of change in the GLY group.

[0046] In this embodiment, a total of 29 candidate differentially expressed metabolites related to glycine supplementation were screened. Among them, 13 metabolites were elevated in the GLY group, and 16 metabolites were decreased in the GLY group. These can be used as indicators to evaluate the fecal metabolic characteristics related to glycine supplementation in late pregnancy. Figure 3 As shown.

[0047] 1.7 KEGG Pathway Enrichment Analysis Candidate differential metabolites associated with glycine supplementation were screened and subjected to KEGG pathway annotation and enrichment analysis to evaluate the effects of glycine supplementation on maternal fecal metabolic characteristics.

[0048] like Figure 3 As shown, in this embodiment, 11 of the 29 candidate differential metabolites were assigned KEGG compound numbers. Among them, the metabolites presumed to be adenosine, guanosine, cyclic guanosine monophosphate, and cortisol can be mapped to relevant metabolic pathways in pigs.

[0049] Adenosine, guanosine, and cyclic guanosine monophosphate all map to purine metabolism pathways; adenosine also maps to the folic acid-mediated one-carbon unit metabolism pathway; and cortisol maps to the steroid hormone biosynthesis pathway.

[0050] Enrichment analysis showed that the purine metabolism pathway reached a significant enrichment level, the folic acid-mediated one-carbon unit metabolism pathway showed an enrichment trend, and the steroid hormone biosynthesis pathway did not reach a significant enrichment level.

[0051] The relative abundance of metabolites presumed to be adenosine, guanosine, and cyclic guanosine monophosphate in the glycine group was higher than that in the CON and ALA groups, indicating that glycine supplementation in late pregnancy may be accompanied by changes in maternal fecal purine metabolism-related characteristics.

[0052] 1.8 Evaluation of placental tissue morphology and vascular density Placental samples were collected after delivery for macroscopic morphological observation, H&E staining, and quantitative analysis of vascular density. Placental sections were H&E stained, photographed under a microscope, and image analysis software such as ImageJ was used to determine the number and area of ​​blood vessels.

[0053] In this embodiment, placental stromal vascular density (PSVD) and placental fold vascular density (PFVD) were used as indicators for evaluating placental vascular development. When selecting fields of view, areas with tissue margins, damaged areas, obvious folds, cavities, and obvious large vessels were excluded; representative areas of the placental matrix and folds were selected for statistical analysis. Multiple fields of view were selected for each sample; the average value of each individual sample was calculated first, followed by intergroup statistical analysis.

[0054] Five 40× placental matrix fields and five 400× placental fold fields were used per sow; PSVD is the percentage of vascular area to matrix area, and PFVD is the number of capillaries per unit area; each sow was averaged and then used as a biological replicate.

[0055] like Figure 4 As shown in the results of this embodiment, compared with the CON group and the ALA group, the placental matrix vascular density and placental fold vascular density were significantly increased in the GLY group (P < 0.05). These results indicate that continuous supplementation with 1.0% glycine before mating and during gestation in gilts can increase vascular density in the placental matrix and placental fold regions, improve placental vascular development-related traits, and thus enhance the exchange of substances between the mother and fetus.

[0056] 1.9 Detection of placental-related gene expression Placental tissue samples were collected during labor, total RNA was extracted and reverse transcribed into cDNA, and qPCR was used to detect the expression levels of genes related to placental vascular function and nutrient transport. A total of nine genes were detected, including vascular function-related genes VEGFA, KDR, and NOS3; amino acid transport-related genes SNAT1 and SNAT2; fatty acid transport-related genes FATP4 and CD36; and glucose transport-related genes GLUT3 and GLUT4.

[0057] ACTB was used as an internal control, with three technical replicates per sample, CON as the calibration group, and relative expression levels were calculated using 2^-ΔΔCt.

[0058] The results showed that the expression of KDR, NOS3, SNAT1, SNAT2, FATP4, and CD36 in the placenta was significantly increased in the glycine group, while the expression of VEGFA was significantly decreased. Changes in GLUT3 and GLUT4 were not entirely consistent. These results suggest that glycine supplementation's improvement of placental function may be mainly related to VEGF receptor signaling response, NO-mediated blood flow regulation, and enhanced amino acid and fatty acid transport capacity. The responses of glucose transport-related genes were relatively inconsistent, while the responses of amino acid and fatty acid transport-related genes were more consistent.

[0059] 1.10 Statistical Analysis Methods After continuous data were tested for normality and homogeneity of variance, one-way ANOVA was used for inter-group comparisons. When the overall treatment effect reached a significant level, Fisher's minimum significant difference method was used for pairwise comparisons between groups.

[0060] The birth litter weight of piglets was analyzed using the number of live piglets as a covariate; the weaning litter weight at 28 days of age was analyzed using the actual number of weaned piglets in each litter as a covariate.

[0061] Proportional data such as pregnancy rate, stillbirth rate, and proportion of low birth weight piglets were evaluated using the Fisher-Freeman-Halton exact test to assess overall inter-group differences, and pairwise comparisons between groups were performed using the Fisher exact test. Microbial alpha diversity was assessed using the Kruskal-Wallis nonparametric test; the correlation between candidate genera and purine metabolism-related metabolites was analyzed using Spearman rank correlation analysis.

[0062] Pregnancy rate was measured using a single gilt as the experimental unit; other reproductive performance and early piglet growth indicators were measured using a litter as the experimental unit; gut microbiota, metabolomics, placental histology, and placental gene expression were all measured using a single gilt as an independent biological replicate.

[0063] General reproductive performance and piglet growth continuity indicators are expressed as mean ± standard error; birth litter weight and 28-day weaning litter weight after covariance analysis are expressed as corrected estimated marginal mean ± standard error; relative abundance of candidate differentially expressed bacterial genera, standardized abundance of metabolites, placental vascular density, and gene expression data are expressed as mean ± standard deviation.

[0064] The relative abundance of candidate bacterial genera and the pairwise comparisons of candidate differential metabolites of D109 were performed using a two-tailed independent samples t-test.

[0065] P < 0.05 is considered statistically significant, and 0.05 ≤ P < 0.10 is considered a trend of difference.

[0066] 2. Results This invention improves the pregnancy rate of gilts and enhances the birth quality and growth performance of piglets during weaning by adding 1.0% glycine to the diet of gilts 30 days before mating and continuing to feed them until farrowing.

[0067] As shown in Table 3, among the sows included in the reproductive performance statistics, the total number of piglets born in the glycine group was 12.00±0.68, and the number of live piglets born was 11.70±0.62, both higher than those in the alanine and other nitrogen control group. The numbers were 9.00±0.63 and 8.60±0.65 respectively. Statistical analysis showed that the total number of offspring and the number of live offspring in the glycine group were significantly higher than those in the alanine and other nitrogen control group, but there was no significant difference compared with the basal diet control group.

[0068] This invention significantly improves the birth quality of piglets. After adjusting for live piglet count, the litter weight of piglets in the glycine group was 14.12±0.62 kg, higher than that of the basal diet control group (11.32±0.56 kg) and the alanine isonitrogen control group (11.63±0.62 kg). The average individual birth weight of piglets in the glycine group was 1.33±0.05 kg, higher than that of the basal diet control group (1.15±0.05 kg) and the alanine isonitrogen control group (1.24±0.06 kg), with an overall increasing trend in inter-group differences (P=0.054), but not reaching a statistically significant level. The proportion of low birth weight piglets in the glycine group was only 3.4% (4 / 117), significantly lower than that of the basal diet control group (15.7% (16 / 102)) and the alanine isonitrogen control group (14.0% (12 / 86)), indicating that glycine supplementation during gestation can improve the overall birth quality of piglets in a litter and reduce the incidence of low birth weight piglets.

[0069] By 28 days of age, after adjusting for the actual number of weaned piglets per litter, the weaning litter weight in the glycine group was 69.00 ± 2.38 kg, significantly higher than the basal diet control group (54.64 ± 2.32 kg) and the alanine isonitrogen control group (53.45 ± 2.44 kg). The average individual weight of piglets in the glycine group at 28 days of age was 6.94 ± 0.26 kg, also significantly higher than the basal diet control group and the alanine isonitrogen control group. These results indicate that although glycine supplementation was stopped at farrowing, the glycine group still exhibited higher weaning litter weight and average individual weight at 28 days of age, suggesting that gestational treatment is associated with improved early growth performance in piglets.

[0070] This invention can also improve pregnancy outcomes in gilts. The pregnancy rate in the glycine group was 100.0% (20 / 20), higher than the 60.0% (12 / 20) in the basal diet control group and the 80.0% (16 / 20) in the alanine and other nitrogen control group, with a significant difference between the glycine group and the basal diet control group. The stillbirth rate in the glycine group was 2.5% (3 / 120), lower than the 8.9% (10 / 112) in the basal diet control group and the 4.4% (4 / 90) in the alanine and other nitrogen control group, but the overall difference in stillbirth rate among the three groups was not statistically significant.

[0071] This invention provides a relatively clear basis for evaluating gut microbiota and metabolic characteristics. On day 109 of gestation, 29 candidate differentially expressed metabolites related to glycine supplementation were obtained according to pre-defined screening criteria. Of these, 13 metabolites were elevated in the glycine group, and 16 were decreased. KEGG pathway enrichment analysis showed significant enrichment in the purine metabolic pathway, with significantly increased relative abundance of metabolites presumed to be adenosine, guanosine, and cyclic guanosine monophosphate. Gut microbiota screening results showed increased relative abundance of *Streptococcus* and decreased relative abundance of CAG-873 in the glycine group. Figure 2 The above-mentioned gut microbiota and metabolomics results indicate that glycine supplementation in late pregnancy is accompanied by changes in maternal gut candidate bacteria and fecal purine metabolism-related characteristics.

[0072] Regarding placental function, compared with the basal diet control group and the alanine-based nitrogen control group, the glycine group showed significantly increased placental matrix vascular density (PSVD) and placental fold vascular density (PFVD), indicating that glycine supplementation can increase vascular density in the placental matrix and fold regions, and improve placental vascular development-related traits. Placental qPCR results showed that the expression of KDR, NOS3, SNAT1, SNAT2, FATP4, and CD36 was significantly increased, while VEGFA expression was significantly decreased in the glycine group; GLUT3 and GLUT4 showed significant changes only in some inter-group comparisons, and the overall response was not as consistent as that of amino acid and fatty acid transport-related genes.

[0073] KDR is an important receptor for VEGFA, and its increased expression indicates an enhanced placental response to VEGF signaling. Increased NOS3 expression is beneficial for nitric oxide production, vasodilation, and blood flow regulation. Although VEGFA mRNA expression decreases during labor, this result is not contradictory to increased placental vascular density. Placental vascular density reflects the cumulative structural results of angiogenesis and vascular remodeling during pregnancy, while VEGFA expression reflects the transcriptional status at the sampling point during labor; its decrease may be related to changes or feedback regulation during late pregnancy placental development.

[0074] Furthermore, the purine metabolism pathway was significantly enriched in the glycine group, with increased relative abundance of adenosine and cyclic guanosine monophosphate-related metabolites. Adenosine is involved in angiogenesis and vasodilation regulation, while NOS3-mediated nitric oxide production and its downstream cGMP signaling are involved in placental vascular function and nutrient transport regulation. Therefore, the changes in purine metabolism, adenosine, and cGMP-related metabolic characteristics are biologically consistent with the increased NOS3 expression and placental vascular density in the glycine group, suggesting that glycine supplementation may improve placental vascular function by regulating purine metabolism-related characteristics, VEGF receptor signaling response, and NO / cGMP-related vascular regulation processes. Since this embodiment detected fecal metabolites and did not directly detect adenosine and cGMP in maternal blood or placental tissue, the above results are used to illustrate the biological associations between related indicators and are not directly limited to a single mechanism of action.

[0075] Meanwhile, the expression of SNAT1 and SNAT2, as well as FATP4 and CD36, was increased in the glycine group. Increased placental vascular density and elevated expression of genes related to amino acid and fatty acid transport together provide evidence for placental function evaluation in the glycine group, which showed increased litter weight at birth, a lower proportion of low birth weight piglets, and higher body weight at 28 days of age.

[0076] This invention is based on the complete compound feed commonly used in farms. It only requires adding glycine at 1.0% of the daily basal ration and feeding it continuously from 30 days before mating until farrowing. It features a clear addition ratio, a well-defined feeding window, simple operation, and ease of promotion. It is suitable for nutritional regulation of gilts of local pig breeds such as local black pigs before mating and during gestation. By increasing gestation rate, birth litter weight, and 28-day weaning litter weight, reducing the proportion of low birth weight piglets, and improving placental vascularity and nutrient transport-related traits, it can reduce production losses caused by low birth weight piglets and has good application value in animal husbandry.

[0077] Table 3. First-parity reproductive performance of gilts and growth performance of piglets It should be noted that when numerical ranges are mentioned in the claims of this invention, it should be understood that the two endpoints of each numerical range and any value between the two endpoints can be selected. To avoid redundancy, the present invention describes preferred embodiments.

[0078] Although preferred embodiments of the invention have been described, those skilled in the art, upon learning the basic inventive concept, can make other changes and modifications to these embodiments. Therefore, the appended claims are intended to be interpreted as including both the preferred embodiments and all changes and modifications falling within the scope of the invention.

Claims

1. Application of glycine in improving the reproductive performance of local black pig replacement gilts, improving litter birth quality and early growth performance of piglets.

2. The application according to claim 1, characterized in that, The improvements include increasing the pregnancy rate of gilts and the litter weight of piglets at birth, reducing the proportion of low birth weight piglets, and increasing the litter weight at 28 days of weaning and the average individual weight at 28 days of age.

3. The application according to claim 1, characterized in that, The glycine is used to increase the density of placental matrix vessels and placental fold vessels in gilts, and to upregulate the expression of placental KDR, NOS3, SNAT1, SNAT2, FATP4 and CD36 genes.

4. The application according to claim 1, characterized in that, The glycine is used as a feed additive and mixed with the daily basal diet for feeding gilts.

5. The application according to claim 4, characterized in that, The basal diet is a complete compound feed that does not contain crystalline glycine.

6. The application according to claim 5, characterized in that, The daily addition of glycine is 1.0% of the daily basal diet of gilts.

7. The application according to claim 6, characterized in that, The feed additives are fed to gilts starting 30 days before mating and continue until farrowing after estrus synchronization and mating.

8. The application according to claim 7, characterized in that, The feed additive is given once daily.